2012 - Study ~ Cannabinoids and atherosclerotic coronary heart disease. Department of Medicine, Division of Cardiology, University of Arkansas for Medical Sciences and VA Medical Center, Little Rock, Arkansas.

2012 - Study ~ The potential use of cannabidiol in the therapy of metabolic syndrome. Medical Weekly.

2011 - Study ~ Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice. Department of Cardiology, University of Freiburg, Germany and Forensic Toxicology, Institute of Forensic Medicine, University Medical Center, Freiburg, Germany.

2011 - Study ~ Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor

Deficient Mice. The Open Cardiovascular Medicine Journal.

2009 - Study ~ Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. National Institute of Health.

2009 - Study ~ Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor. Drug Metabolism ans Disposition.

2009 - Study ~ Cannabinoids and atherosclerosis. Prague Medical Report.

2009 - Study ~ The emerging role of the endocannabinoid system in cardiovascular disease. Oxidative Stress Tissue Injury, Laboratory of Physiological Studies, National Institutesof Health.

2009 - Study ~ Endocannabinoids and the Heart. Department of Pharmacology, University of Cambridge, England.

2008 - Study ~ Cannabinoid receptors in acute and chronic complications of atherosclerosis. British Journal of Pharmacology.

2008 - Study ~ Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases. American Journal of Physiology.

2008 - Study ~ CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. American Journal of Physiology.

2007 - Study ~ Endocannabinoids and the haematological system. British Journal of Pharmacology.

2007 - Study ~ Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. National Institute of Health.

2007 - Study ~ Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. National Institute of Health.

2007 - Study ~ Cannabinoids and cardiovascular disease: the outlook for clinical treatments. Current Vascular Pharmacology.

2006 - Study ~ The Cannabinergic System as a Target for Anti-inflammatory Therapies. Current Topics in Medicinal Chemistry.

2006 - Study ~ Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis. Future Medicine.

2006 - Study ~ Does Cannabis Hold the Key to Treating Cardiometabolic Disease? Clinical Practice in Cardiovascular Medicine.

2005 - Study ~ Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature International Journal of Science.

1981- Study ~ Cannabinoids impair the formation of cholesteryl ester in cultured human cells. Arteriosclerosis, Thrombosis, and Vascular Biology.

Top